{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bayside",
      "state": "NY",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74144",
      "recalling_firm": "SOS Telecom Inc.",
      "address_1": "20228 45th Ave",
      "address_2": "N/A",
      "postal_code": "11361-2540",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "NY",
      "recall_number": "D-0101-2017",
      "product_description": "Tiger-X, 1200 mg, 1 capsule per pack , 24 single packs per box",
      "product_quantity": "N/A",
      "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements",
      "recall_initiation_date": "20160512",
      "center_classification_date": "20161014",
      "termination_date": "20180706",
      "report_date": "20161026",
      "code_info": "Lot No: 9236999; Best use by: 12/16/2016"
    }
  ]
}